SemiLEDs Reports First Quarter Fiscal Year 2019 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
26
SemiLEDs Reports First Quarter Fiscal Year 2019 Financial Results

HSINCHU, Taiwan, Jan. 10, 2019 (GLOBE NEWSWIRE) -- SemiLEDs Corporation (NASDAQ: LEDS), “SemiLEDs” or the “Company,” a developer and manufacturer of LED chips and LED components, today announced its financial results for the first quarter of fiscal year 2019, ended November 30, 2018.

Revenue for the first quarter of fiscal 2019 was $972 thousand, a 50% decrease compared to $2.0 million in the fourth quarter of fiscal 2018. GAAP net loss for the first quarter of fiscal 2019 was $983 thousand, compared to a loss of $1.1 million in the fourth quarter of fiscal 2018, or a net loss of $0.27 per diluted share, compared to a net loss of $0.32 per diluted share for the fourth quarter of fiscal 2018. Due to the excess capacity charges that we have experienced for the last few years, considering the risk of technological obsolescence and based on the sales forecast production, we disposed of certain of our idle equipment during the first quarter of fiscal 2019, which reduced our net loss.

GAAP gross margin for the first quarter of fiscal 2019 was negative 23%, compared with gross margin for the fourth quarter of fiscal 2018 of negative 11%. Operating margin for the first quarter of fiscal 2019 was negative 105%, compared with negative 62% in the fourth quarter of fiscal 2018. The Company’s cash and cash equivalents was $2.6 million at November 30, 2018, compared to $3.4 million at the end of fiscal 2018.

We expect revenue for the second quarter ending February 28, 2019 to be about $1.5 million +/- 10%.

The Chinese New Year (CNY) of 2019 will begin on February 4, 2019. Our office and factory in Chunan will be closed from February 2, 2019 until February 17, 2019 and will resume operations on Monday, February 18, 2019.

About SemiLEDs

SemiLEDs develops and manufactures LED chips and LED components for general lighting applications, including street lights and commercial, industrial, system and residential lighting, along with specialty industrial applications such as ultraviolet (UV) curing, medical/cosmetic, counterfeit detection, horticulture, architectural lighting and entertainment lighting. SemiLEDs sells blue, white, green and UV LED chips.

Forward Looking Statements

This press release contains statements that may constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, any projection of future revenues, any statements about historical results that may suggest trends for SemiLEDs’ business; any statements of the plans, strategies and objectives of management for future operations; any statements of expectation or belief regarding recovery of the LED industry, market opportunities and other future events or technology developments; any statements regarding SemiLEDs’ position to capitalize on any market opportunities; and any statements of assumptions underlying any of the foregoing. These forward-looking statements are based on current expectations, estimates, forecasts and projections of future SemiLEDs’ or industry performance based on management’s judgment, beliefs, current trends and market conditions and involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. SemiLEDs’ Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) and other SemiLEDs filings with the SEC (which you may obtain for free at the SEC’s website at http://www.sec.gov) discuss some of the important risks and other factors that may affect SemiLEDs’ business, results of operations and financial condition. SemiLEDs undertakes no intent or obligation to publicly update or revise any of these forward looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contacts:

Christopher Lee
Chief Financial Officer
SemiLEDs Corporation
+886-37-586788
investor@semileds.com

 
SEMILEDS CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Balance Sheets
(In thousands of U.S. dollars)
 
    November 30,     August 31,    
    2018     2018    
ASSETS                  
CURRENT ASSETS:                  
Cash and cash equivalents   $ 2,574     $ 3,421    
Accounts receivable (including related parties), net     183       282    
Inventories     2,220       1,818    
Prepaid expenses and other current assets     378       340    
Total current assets     5,355       5,861    
Property, plant and equipment, net     6,678       7,213    
Intangible assets, net     95       98    
Investments in unconsolidated entities     910       914    
Other assets     175       164    
TOTAL ASSETS   $ 13,213     $ 14,250    
LIABILITIES AND EQUITY                  
CURRENT LIABILITIES:                  
Current installments of long-term debt   $ 335     $ 335    
Accounts payable     634       894    
Advance receipt toward the convertible note     500       500    
Accrued expenses and other current liabilities     5,580       5,505    
Total current liabilities     7,049       7,234    
Long-term debt, excluding current installments     1,921       2,013    
Total liabilities     8,970       9,247    
Commitments and contingencies                  
EQUITY:                  
SemiLEDs stockholders’ equity                  
Common stock     —       —    
Additional paid-in capital     175,698       175,527    
Accumulated other comprehensive income     3,732       3,727    
Accumulated deficit     (175,229 )     (174,251 )  
     Total SemiLEDs stockholders’ equity     4,201       5,003    
Noncontrolling interests     42       —    
Total equity     4,243       5,003    
TOTAL LIABILITIES AND EQUITY   $ 13,213     $ 14,250    
                   


 
SEMILEDS CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Operations
(In thousands of U.S. dollars and shares, except per share data)
 
    Three Months Ended    
    November 30,     August 31,    
    2018     2018    
Revenues, net   $ 972     $ 1,950    
Cost of revenues     1,191       2,155    
Gross profit (loss)     (219 )     (205 )  
Operating expenses:                  
Research and development     334       254    
Selling, general and administrative     757       871    
Gain on disposals of long-lived assets     (288 )     (112 )  
Total operating expenses     803       1,013    
Loss from operations     (1,022 )     (1,218 )  
Other income (expenses):                  
Equity in loss from unconsolidated entities     —       (8 )  
Interest expenses, net     (5 )     (5 )  
Other income, net     80       155    
Foreign currency transaction gain (loss), net     (36 )     (55 )  
Total other income (expenses), net     39       87    
Loss before income taxes     (983 )     (1,131 )  
Income tax expense     —       —    
Net loss     (983 )     (1,131 )  
Less: Net loss attributable to noncontrolling interests     (5 )     —    
Net loss attributable to SemiLEDs stockholders   $ (978 )   $ (1,131 )  
Net loss per share attributable to SemiLEDs stockholders:                  
Basic and diluted   $ (0.27 )   $ (0.32 )  
Shares used in computing net loss per share attributable to SemiLEDs stockholders:                  
Basic and diluted     3,560       3,559    
                   

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 11

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 5

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 3

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Automotive Fabrics: Sustainability Meets Innovation

Updated Category News Views 190

Emerging Trends in the Automotive Fabrics Market The global automotive fabrics market is undergoing a remarkable transformation. With consumers increasingly prioritizing sustainable and eco-friendly options, manufacturers are adapting their product offerings to meet these preferences. The rise of electric vehicles (EVs) has further accelerated the focus on...

Continue Reading
GENFIT Partners for Royalty Financing to Strengthen Pipeline

Updated Category News Views 238

GENFIT Partners with HealthCare Royalty for Financial Growth GENFIT, a prominent biopharmaceutical company, has announced a landmark agreement with HealthCare Royalty (HCRx) to secure up to €185 million in non-dilutive capital. This financial move is designed to bolster GENFIT's resources while ensuring the company remains strong in the evolving biopharma landscape....

Continue Reading
Kuros Biosciences Achieves Remarkable Sales Growth in 2025

Updated Category News Views 508

Kuros Biosciences Achieves Remarkable Sales Growth in 2025 Financial & Operational Highlights Direct sales of the MagnetOs™ product grew by 79% with revenue reaching USD 28.4 million in Q1 2025 (up from USD 15.8 million in the same quarter of the previous year). Total Medical Device sales surged by 82% to USD 28.8 million, marking the first time monthly revenues...

Continue Reading
Kyle Bass Critiques ESG Investing Strategies

Updated Category News Views 110

Challenges in Environmental, Social, and Governance Investing Kyle Bass, a seasoned hedge fund manager and founder of Hayman Capital Management, shares his perspective on the hurdles associated with Environmental, Social, and Governance (ESG) investing. He believes that the backlash against ESG strategies largely arises from climate activists who demand an immediate end...

Continue Reading
ZOYA Nail Essentials Receives Recognition from Oprah Daily 2025

Updated Category News Views 220

ZOYA's Nail Essentials Kit Recognized in Oprah's Favorite Things In an exciting announcement from ZOYA, the ZOYA Nail Essentials Healthy Color + Treatment Kit has been featured on the prestigious 2025 list of Oprah's Favorite Things. This acknowledgment comes from a cherished holiday list where innovative and inspiring products are highlighted, making them a go-to for...

Continue Reading